OUR STORY
Vitara Biomedical is a medical technology company on a mission to reinvent the standard of care for extremely premature newborns. Founded in 2019 and headquartered in Philadelphia, Vitara is backed by leading venture capital firms and built on decades of pioneering neonatology research from the Children’s Hospital of Philadelphia.
OUR PEOPLE
The Team Behind Vitara
Kim Rodriguez
Chief Executive Officer (CEO)
Marcus Davey, PHD
Co-Inventor, VP Preclinical Research
Janene Fuerch MD
Neonatology Advisor
Brian Bergeron
Chief Operations Officer
Noah Bartsch
EVP Clinical, Regulatory and Quality
Chris Gregory, PHD
VP Research & Development
Monica Ferrante
VP Regulatory
Miki Silver
VP of Engineering
Sean O’Connor
Sr. Director of Engineering
Erin Kriebel
Sr. Director of Quality
Board of Directors
Tom Todorow
Chief Financial Officer, Children's Hospital of Philadelphia
Joe Andrasko
Chief Executive Officer, Chief Investment Officer, Sands Capital Horizon
Dan Fields
Senior Vice President & Chief Strategy Officer, Children’s Hospital of Philadelphia
Ted Fjaellman
Chief Executive Officer, Flerie
Cathy Friedman
Executive Venture Partner, GoogleVentures
Jun Jeon
Partner, Khosla Ventures - Healthcare, Biology, and Technology
Manish Kothari
Managing Director, First Sparks Ventures
Bernie Lyons
Operating Partner, Altaris Capital Partners
Jake Merrill
Principal, Sands Capital
Diem Nguyen
Chief Executive Officer, SIGA Technologies
Ian Ratcliffe
Executive Managing Partner, Sands Capital
Martin Varsavsky
Chairman, Inception Prelude Fertility, Overture and Gameto MVB Fund, and CEO, Jazzya
OUR MISSION
To reinvent the standard of care for extremely premature newborns.
OUR VISION
To give extremely premature newborns and their families a lifetime of possibilities.